Publications
74
Citations
1,847
Est. group size
—
Recurring co-author estimate
Active years
30
Publishing since 1997
Soosung Kang's research focuses on medicinal chemistry and drug discovery, particularly designing and testing small-molecule inhibitors for diseases such as pulmonary fibrosis, cancer, and Alzheimer's disease. Recent work also incorporates computational and machine-learning approaches, including AI-based prediction of drug-target interactions and automated drug property forecasting, alongside traditional lab-based chemical synthesis and biological testing.
Publication output has been fairly steady over the last decade, fluctuating between 2 and 7 papers per year without a clear long-term increase or decline.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- EnsDTI: Predicting Drug-Target Interaction With Mixture-of-Experts and Confidence Assessment
IEEE Transactions on Computational Biology and Bioinformatics · 2026
- 4-Hydroxyderricin from Angelica keiskei promotes the stability of BRCA1 in triple-negative breast cancer cells through inhibition of cathepsin S
Phytochemistry · 2026
- Discovery of triazolyl azabicyclo[3.1.0]hexane derivative as an autotaxin inhibitors for the treatment of pulmonary fibrosis
European Journal of Medicinal Chemistry · 2026
- Employing Automated Machine Learning (AutoML) Methods to Facilitate the <i>In Silico</i> ADMET Properties Prediction
Journal of Chemical Information and Modeling · 2025
- Targeting Autotaxin with imidazole- and Triazolyl-based inhibitors: Biological insights from in vitro and in vivo studies in pulmonary fibrosis
Bioorganic Chemistry · 2025
- Correction to “Development of a Fluorescence Probe for High-Throughput Screening of Allosteric Inhibitors Targeting TRAP1”
Journal of Medicinal Chemistry · 2025
- FragDockRL: A Reinforcement Learning Method for Fragment-Based Ligand Design via Building Block Assembly and Tethered Docking
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Development of a Fluorescence Probe for High-Throughput Screening of Allosteric Inhibitors Targeting TRAP1
Journal of Medicinal Chemistry · 2024
- Mixture-of-Experts Approach for Enhanced Drug-Target Interaction Prediction and Confidence Assessment
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Tsaokoic Acid: A New Bicyclic Nonene from the Fruits of Amomum tsao-ko with Acetylcholinesterase Inhibitory Activity
Molecules · 2023
- Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis
Journal of Medicinal Chemistry · 2023
- EnsDTI-kinase: Web-server for Predicting Kinase-Inhibitor Interactions with Ensemble Computational Methods and Its Applications
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1
Journal of Medicinal Chemistry · 2022
- 2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPα Checkpoint
ACS Medicinal Chemistry Letters · 2022
- Triphenylphosphonium conjugation to a TRAP1 inhibitor, 2-amino-6-chloro-7,9-dihydro-8H-purin-8-one increases antiproliferative activity
Bioorganic Chemistry · 2022
- Journal of Medicinal Chemistry×7
- Molecules×3
- Bioorganic Chemistry×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Journal of the American Chemical Society×2
- Elsayed M. Mahgoup
Medicine · The Ohio State University
- Anna Leone
Medicine · The Ohio State University
- Craig Hemann
Medicine · The Ohio State University
- Bhavani Gopalakrishnan
Medicine · Purdue University West Lafayette
- Jason A. Scott
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile